Arthrosi Investigative Site (604) — Fort Mill, South Carolina

Arthrosi Investigative Site (604) is a clinical research site located in Fort Mill, South Carolina, United States 29707.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Arthrosi Investigative Site (604) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gout, Arthritis, Gouty, Hyperuricemia.

Sponsors: Arthrosi Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Mill

Browse all research sites in South Carolina · View every site in Fort Mill

• Piedmont Research Partners
• GSK Investigational Site
• Research Site
• Novartis Investigative Site
• Forest Investigative Site 1914
• Chiesi Clinical Trial Site 840211
• Nichi-Iko Investigational Site
• Chiesi Investigational Site
• Shiland Family Practice
• Investigational Site Number 8408060
• 205.479.01026 Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arthrosi Investigative Site (604)?

Arthrosi Investigative Site (604) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arthrosi Investigative Site (604) conducted?

Arthrosi Investigative Site (604) has 1 clinical trials on record, with 1 currently active. Their work covers Gout, Arthritis, Gouty, Hyperuricemia.

Is Arthrosi Investigative Site (604) accredited by Crixeo Clinical Trials?

Arthrosi Investigative Site (604) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arthrosi Investigative Site (604)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.